Safe Sedation (Short)
-
Upload
neelmakhan5748 -
Category
Documents
-
view
218 -
download
0
Transcript of Safe Sedation (Short)
-
8/9/2019 Safe Sedation (Short)
1/39
Safe sedation
Dr M F Haque
CDOS, Oral Surgery
Institute of Dentistry, QMUL
-
8/9/2019 Safe Sedation (Short)
2/39
Overview
What is sedation?
Oral sedation
Inhalational sedation
Intravenous sedation
Midazolam and Flumazenil
Practicalities
Hot tips
-
8/9/2019 Safe Sedation (Short)
3/39
Sedation
Conscious sedation
Deep sedation Anaesthesia
-
8/9/2019 Safe Sedation (Short)
4/39
Conscious Sedation
Is just one facet of anxiety management for
dental patients
All patients must have their level of anxietyassessed and appropriate measures put in
place to help
Conscious sedation is a useful method ofanxiety management for anxious patients who
are unable to respond to non-pharmacological
technique
-
8/9/2019 Safe Sedation (Short)
5/39
Conscious sedation
A technique in which the use of a drug or drugs
produces a state of depression of the centralnervous system enabling treatment to be carried
out,
but during which verbal contact with the patient
is maintained throughout the period of sedation.
(General Dental Council)
-
8/9/2019 Safe Sedation (Short)
6/39
Conscious sedation
The drugs and techniques used to provide
conscious sedation for dental treatment should
carry a margin of safety wide enough to render
loss of consciousness unlikely
The ability to maintain a patient airway is the
important distinguishing feature
Under no circumstances be interpreted as light
general naesthesia
-
8/9/2019 Safe Sedation (Short)
7/39
Why go for sedation?
Nervousness, and fear:
Normal physiological / psychological responses
resulting from anticipation of what is about to
happen particularly if this is unknown
Anxiety:
- an emotion similar to fear but without any
objective evidence of danger
- involves physiological, behavioural and
psychological reactions by the individual
- it often synonymous with stress
-
8/9/2019 Safe Sedation (Short)
8/39
Continued-
Stress:
- The physiological and behavioural response
resulting from a lack ofharmony between an
individual and their environment- usually caused by stressors i.e. a stimuli
which cause stress
Phobia: An extreme instanse of anxiety which creates a
pattern of total avoidance behaviour
-
8/9/2019 Safe Sedation (Short)
9/39
Standard techniques
Intravenous sedation with Midazolam alone
Inhalantional sedation using Entnox (=Nitrous
oxide and Oxygen)
Oral/transmucosal Benzodiazepine
-
8/9/2019 Safe Sedation (Short)
10/39
Alternative Techniques
Any form of conscious sedation under 12 year
olds other than Entonox
Benzodiazepines plus any other intravenousagent (Opioid, Propofol, Ketamine)
Propofol either alone or in combination
Inhalational sedation using any agent other than
Nitrous Oxide
Combined routes of administration
-
8/9/2019 Safe Sedation (Short)
11/39
Types of sedation
Oral sedation
Oral Benzodiazepines
Inhalational sedation Nitrous Oxide
Anaesthetic agents (Sevoflurane)
Intravenous sedation Intravenous Benzodiazepines
Opioids
Anaesthetic agents
-
8/9/2019 Safe Sedation (Short)
12/39
Oral sedation
Oral or intranasal sedation should only be used
when it is not possible to use a titrateable
technique
Does not allow accurate titration against the
patients response
Risk of under- or over sedation with fixed dose
-
8/9/2019 Safe Sedation (Short)
13/39
Oral sedation II
Absorption and excretion unpredictable
Benzodiazepines
- Temazepam
- Lorazepam
- Diazepam
-
8/9/2019 Safe Sedation (Short)
14/39
Nitrous Oxide
Relative analgesia
- Mixture of nitrous oxide and oxygen
- Quantiflex machine
- Minimum 30% O2
Laughing gas
Colourless gas
Sweet and pleasant
Smelling
Scavenging
Effects on staff
-
8/9/2019 Safe Sedation (Short)
15/39
Nitrous oxide
Non-irritant
Rapidly absorbed
Low solubility in blood
Very quick recovery
Excreted by lungs
No central respiratory depression
-
8/9/2019 Safe Sedation (Short)
16/39
Health and safety guidelines
Occupational exposure to nitrous oxide should
not exceed 100 ppm over 8 hour period
Maximum of 2.5 hours per day in the sedation
environment to remain within the occupational
exposure limit
-
8/9/2019 Safe Sedation (Short)
17/39
Sevoflurane
Volatile anaesthetic agent
Flurinated ether
Scavenging
Causes CVS and respiratory depression
Apnoea common
-
8/9/2019 Safe Sedation (Short)
18/39
Intravenous sedation
Benzodiazepines
-Midazolam
- (Diazepam)
NMDA receptor antagonists
- Ketamine
Opioids
- Fentanyl
- Remifentanil Anaesthetic agents
- Propofol
-
8/9/2019 Safe Sedation (Short)
19/39
Advantages of intravenous sedation
Given remote from operating site
Administered as a single titrated dose
Titrateable to desired effect
Rapid onset (arm to brain time)
Mouth breathing not relevant
-
8/9/2019 Safe Sedation (Short)
20/39
Disadvantages of intravenous
sedation
Overdose may lead to profound respiratory
depression or even apnoea
Depression of laryngeal reflexes
-
8/9/2019 Safe Sedation (Short)
21/39
Opioids
Fentanyl
Synthetic primary Q-
opioid agonist 2 ml ampoules with
50 micrograms/ml
25 micrograms
Remifentani
Synthetic pure Q-
opioid agonist Ultrafast acting
Needs infusion
Serious potential
complications
-
8/9/2019 Safe Sedation (Short)
22/39
Ketamine
NMDA-receptor antagonist
Anaesthetic induction drug
Class C drug in UK
Good analgesic properties at sub-anaestheticdose
Slow recovery
High incidence of extraneous muscle
movements
Hallucinations
-
8/9/2019 Safe Sedation (Short)
23/39
Propofol
Diprivan (shortened version ofDI-isoPRopyl IV
Anaesthetic)
Anaesthetic induction agent
Pain on injection
Monitored Anaesthesia Care Sedation
Usually as infusion
-
8/9/2019 Safe Sedation (Short)
24/39
Midazolam profile
Selective impairment of memory
Minimal depression of ventilation or
cardiovascular system Specific site of action
Relative safety if taken in overdose
Low abuse and physical dependence potential
Specific antagonist available
-
8/9/2019 Safe Sedation (Short)
25/39
Midazolam: pharmacokinetics II
Onset of action: 2 minutes
Distribution half life: 6-15 minutes
Elimination half life: 1.5-6.4 hours
Metabolized in liver y cytochrome P450-3A4
Active metabolites
Interactions with grapefruit juice, Erythromicin,
Verapamil: higher plasma concentrations
-
8/9/2019 Safe Sedation (Short)
26/39
Midazolam: mechanism of action
Benzodiazepine receptors on the alpha subunits
of the GABA-A receptor
Enhance chloride gating function ofGABA
Hyperpolarization of cell membranes
GABA receptors almost exclusively in CNS
(cerebral cortex)
-
8/9/2019 Safe Sedation (Short)
27/39
Midozolam: body effects
Dose related decreases in cerebral blood flow
Respiratory depression and apnoea
Minimal cardiovascular changes (can lower
blood pressure)
Suppression ofhypothalamic-pituitary adrenal
axis
Paradoxical effects!
-
8/9/2019 Safe Sedation (Short)
28/39
Reported Adverse Effects
Hiccups 3.9%
Nausea 2.8%
Vomiting 2.6% Coughing 1.3%
Over-sedation 1.6%
Headache 1.5%
Drowsiness 1.2%
Local effects at the IV site:
Tenderness 5.6%
Pain during injection 5% Redness 2.6%
Induration
Phlebitis 0.4%
-
8/9/2019 Safe Sedation (Short)
29/39
Midozolam: contraindications
Hypersensitivity
Acute narrow angle glaucoma
Hypotension
Shock
Alcohol abuse
Head injury
Pregnancy Foetal malformations?
Withdrawal, hypotonia, apnoea, cyanosis in
newborn
-
8/9/2019 Safe Sedation (Short)
30/39
Midozolam: effects
1. Sedation
2. Anxiolysis
3. Hypnosis
4. Muscle relaxation
5. Anterograde amnesia
6. Anti-epileptic
-
8/9/2019 Safe Sedation (Short)
31/39
Signs of sedation
Relaxation
Delayed response
Slurred speech
Verrils signs- Ptosis
No hyperventilation
Lowered heart rate
Best signs:
Slurred speech and regular breathing
-
8/9/2019 Safe Sedation (Short)
32/39
Midazolam: overdose
Death
Coma
Impaired motor function
- Impaired reflexes
- Impaired coordination
- Impaired balance
Hypotension Mental confusion
Somnolence
-
8/9/2019 Safe Sedation (Short)
33/39
Flumazenil
Specific benzodiazepine antagonist
High affinity for receptor
Minimal agonist activity
Reverse effects within 2 minutes
Half life shorter than that of midazolam
May require repeated doses
-
8/9/2019 Safe Sedation (Short)
34/39
Flumazenil Preparations
Flumazenil (non-proprietary)
100 micrograms/ml, 5ml 14.49
Anexate
100 micrograms/ml, 5ml 14.49
-
8/9/2019 Safe Sedation (Short)
35/39
Flumazenil Doses
200 micrograms over 15 seconds, then 100
micrograms at 60 second intervals
Usual dose range 300-600 micrograms
Maximal dose 1mg
-
8/9/2019 Safe Sedation (Short)
36/39
Practicalities
Draw up midazolam to have 1 mg/ml: 1 ampoule
of midozolam diluted into 10 ml syringe
Have Flumazenil checked and ready
Know exactly where all your emergency
equipment is
-
8/9/2019 Safe Sedation (Short)
37/39
Patients
-
8/9/2019 Safe Sedation (Short)
38/39
Patients >60 years or concomitant
disease Danger ofhypoventilation, apnoea and airway
obstruction
Peak effect may take longer Smaller increments and slower rate of injection
No more than 1.5 mg over 2 minutes
Increments of 1 mg
Take time to evaluate response
Total dose 3.5 mg usually enough
-
8/9/2019 Safe Sedation (Short)
39/39
Hot tips
Never give more than 2 mg in one go
Total dose should not exceed 5 mg
Keep verbal contact with your patient
Know when to bail out
Take your time: sedation cannot be rushed
Remember: Sedation not Analgesia